(NYSE: COR) Cencora's forecast annual revenue growth rate of 6.35% is not forecast to beat the US Medical Distribution industry's average forecast revenue growth rate of 7.91%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.07%.
Cencora's revenue in 2025 is $303,192,826,000.On average, 6 Wall Street analysts forecast COR's revenue for 2025 to be $61,607,907,420,781, with the lowest COR revenue forecast at $56,926,317,983,628, and the highest COR revenue forecast at $62,953,163,933,647. On average, 6 Wall Street analysts forecast COR's revenue for 2026 to be $66,105,560,688,145, with the lowest COR revenue forecast at $61,480,421,870,982, and the highest COR revenue forecast at $67,647,256,562,497.
In 2027, COR is forecast to generate $70,749,539,907,245 in revenue, with the lowest revenue forecast at $66,245,158,492,804 and the highest revenue forecast at $72,713,669,988,786.